Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Clinical trial NCT06855537 · RECRUITING

Trial details

NCT number: NCT06855537
Sponsor: Beijing Anzhen Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Arterial Disease (CAD)Vulnerable Coronary Plaques Thin-cap fIbroatheroma Acute Coronary Syndromes (ACS)

Start date: 2025-11-03
Primary completion: 2027-09-01
Enrollment: 2190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.